Oh No, Please Not Another Article about AI!

Posted

By Lisa Suennen, CEO, Venture Valkyrie July 2023 – Yesterday I was chatting with an interesting person who works closely with young companies and who himself is considering whether he should further his own education in health tech.  He asked me this question:  What are the biggest challenges in the adoption of AI in healthcare… Read more »

How I Moved from Operating Executive at a Fortune 50 Payer to a Board Member and Angel Advisor/Investor Driving Health Care Transformation

Posted

By Nancy Cocozza, Advisor and Board Member June 2023 – By just about any measure, I’ve been fortunate to have had a long, thoroughly enjoyable (sometimes arduous) career, building and turning around Medicare health plan businesses for large payers over the past two decades.  The bigger the business, the more complex the challenges and often… Read more »

The Opportunity of Rising Behavioral Health Utilization

Posted

by Michael Shepherd, MD, CPA, MBA March 2023 – Since the beginning of the COVID-19 pandemic, rates of patients experiencing anxiety or depression symptoms have increased 25%, behavioral health care providers have seen increasing requests for behavioral health services exacerbating pre-covid access issues and, emergency rooms have seen an increasing number of pediatric patients seeking… Read more »

Every Company in Healthcare Should Have a ‘Code Red’ Team for AI

Posted

by Geoff Halstead, Fraction Chief Product Officer and Digital Business Strategist February 2023 – For the last year, experts across the entire breadth of the technology industry – business and technical leaders, entrepreneurs, observers and venture capitalists alike – have been proclaiming that we have crossed over a critical threshold or ‘tipping point’ in the… Read more »

Real World Evidence Can Make Drugs More Affordable

Posted

by Jennifer Stacey, SVP of Clinical Sciences & Operations, TriNetX January 2023 – It should be no surprise that profitability is the primary goal for pharmaceutical companies, as it allows them to continue to fund research and development (R&D) of new drugs, pay dividends to shareholders, and support their business operations. The truthful way to… Read more »

Enabling Aggressive Growth Plans While Preserving Capital

Posted

by Colin Dittus, VP Consulting, Gibson Consultants December 2022 – At a time when the macroeconomic environment has made funding for healthcare startups increasingly challenging, employing the best talent strategies has become more critical than ever.  The companies that stand out and win the battles both for investment dollars and market share will be those… Read more »